Literature DB >> 19430238

What is the significance of thrombocytosis in patients with trauma?

Ali Salim1, Pantelis Hadjizacharia, Joseph DuBose, Leslie Kobayashi, Kenji Inaba, Linda S Chan, Daniel R Margulies.   

Abstract

BACKGROUND: The incidence and risk factors for the development of thrombocytosis after trauma have not been well established. Although it has been suggested that the occurrence of this sequela may be associated with adverse events, there are also limited data regarding outcomes of patients developing posttraumatic thrombocytosis. The objective of this study was to determine the incidence of, risk factors for, and sequela of posttraumatic thrombocytosis.
METHODS: A retrospective review of all trauma intensive care unit (ICU) admissions between July 1998 and December 2005 identified patients with early (< or = 7 days), late, and no thrombocytosis. Bivariate analysis was used to compare the clinical and demographic characteristics with outcomes between the three patient groups.
RESULTS: A total of 3,484 patients were admitted to the ICU during the 7-year study period. After exclusions, the study population consisted of 3,286 patients. The overall incidence of thrombocytosis was 18.7%; early thrombocytosis was found in 72 patients, and late thrombocytosis was identified in 542 patients. All complications examined were significantly higher in patients with thrombocytosis. Overall, the venous thromboembolic rate was 2.4%; for patients with thrombocytosis it was 4.6% compared with 1.9% in patients without thrombocytosis. Overall mortality was 15.4%, but was significantly lower in patients with thrombocytosis (3.8% vs. 18.1%, p < 0.0001). Independent risk factors for the development of thrombocytosis included obesity, laparotomy, blunt injury, Injury Severity Score > 16, mechanical ventilation, Chest Abbreviated Injury Score > 3, and tachycardia.
CONCLUSION: Thrombocytosis is a common finding among patients with trauma admitted to the ICU. The occurrence of both early and late thrombocytosis is associated with significantly higher rates of complications, particularly venous thromboembolism. However, patients developing posttraumatic thrombocytosis may have a significantly lower mortality compared with those without this sequela of injury.

Entities:  

Mesh:

Year:  2009        PMID: 19430238     DOI: 10.1097/TA.0b013e318191b8af

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  12 in total

1.  Etiology and clinical relevance of elevated platelet count in ICU patients : A retrospective analysis.

Authors:  M Banach; C Lautenschläger; P Kellner; J Soukup
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-03-31       Impact factor: 0.840

2.  Extreme thrombocytosis in a traumatic patient.

Authors:  Hyun-Hea Kim; Byung-Sang Lee; Kyoung Seok Kweon; Dae-Eun Kweon; Tae-Gyu Lee
Journal:  Korean J Anesthesiol       Date:  2013-03-19

3.  Thrombocytosis after hip and knee surgery in the rehabilitation setting: is it an occasional phenomenon? Relationship with deep venous thrombosis and functional outcome.

Authors:  Domenico Intiso; Filomena Di Rienzo; Andrea Iarossi; Massimiliano Copetti; Luigi Pazienza; Mario Russo; Maurizio Tolfa; Giuseppe Maruzzi
Journal:  BMC Musculoskelet Disord       Date:  2015-04-15       Impact factor: 2.362

4.  Platelet count abnormalities and peri-operative outcomes in adults undergoing elective, non-cardiac surgery.

Authors:  Isabel A Weil; Prateek Kumar; Sinziana Seicean; Duncan Neuhauser; Andreea Seicean
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

5.  Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy.

Authors:  Jing-Chun Song; Li-Kun Yang; Wei Zhao; Feng Zhu; Gang Wang; Yao-Peng Chen; Wei-Qin Li
Journal:  Mil Med Res       Date:  2021-04-12

6.  Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.

Authors:  Sisse R Ostrowski; Ronan M G Berg; Nis A Windeløv; Martin A S Meyer; Ronni R Plovsing; Kirsten Møller; Pär I Johansson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

7.  Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

Authors:  Hilde Jensvoll; Kristine Blix; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

8.  Systemic effects induced by intralesional injection of ω-conotoxin MVIIC after spinal cord injury in rats.

Authors:  Karen M Oliveira; Carla Maria O Silva; Mário Sérgio L Lavor; Isabel R Rosado; Fabíola B Fukushima; Anna Luiza Fv Assumpção; Saira Mn Neves; Guilherme R Motta; Fernanda F Garcia; Marcus Vinícius Gomez; Marília M Melo; Eliane G Melo
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-04-16

9.  Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach.

Authors:  Daniel Rittirsch; Veit Schoenborn; Sandro Lindig; Elisabeth Wanner; Kai Sprengel; Sebastian Günkel; Barbara Schaarschmidt; Sonja Märsmann; Hans-Peter Simmen; Paolo Cinelli; Michael Bauer; Ralf A Claus; Guido A Wanner
Journal:  Crit Care       Date:  2015-11-26       Impact factor: 9.097

10.  Predictable Risk Factors of Upper-Extremity Deep Venous Thrombosis in a Level I Trauma Center.

Authors:  Scarlett Tohme; Aparna Vancheswaran; Kyle Mobbs; Jessica Kydd; Nisha Lakhi
Journal:  Int J Gen Med       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.